Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols
NCT00026689 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 903
Last updated 2019-12-12
Summary
Background:
-This protocol will provide a means for screening potential candidates for NCI Radiation Oncology Branch (ROB) protocols.
Objectives:
-To permit evaluation of patients referred to the NCI Radiation Oncology Branch in order to identify individuals who will be suitable candidates for Radiation Oncology Branch clinical research protocols.
Eligibility:
-Patients suspected of having, or with biopsy proven malignant disease or patients with a benign condition for whom radiotherapy is a potential treatment.
Design:
-This is a screening protocol. No investigational treatments will be administered on this protocol.
Conditions
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Principal Investigators
-
Kevin A Camphausen, M.D. · National Cancer Institute (NCI)
Eligibility
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-09-11
- Completion
- 2019-02-25
Countries
- United States
Study Locations
More Related Trials
-
Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer
NCT00048997 ·Status: COMPLETED ·Phase: PHASE3
-
Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC
NCT02688036 ·Status: UNKNOWN ·Phase: PHASE3
-
A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung Cancer
NCT05138900 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
NCT00750269 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stereotactic Body Radiation for Consolidation After Standard Chemoradiation for Stage 3 Lung Cancer
NCT01656460 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Radiotherapy With Different Fractionation Modes for the Early Lung Cancer
NCT05802641 ·Status: UNKNOWN
-
Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients
NCT01968941 ·Status: COMPLETED ·Phase: PHASE3
-
Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease
NCT00001295 ·Status: COMPLETED
-
Proton Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer
NCT01525446 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC
NCT02314364 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
NCT00960999 ·Status: COMPLETED ·Phase: PHASE2
-
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
NCT06686771 ·Status: RECRUITING ·Phase: PHASE3
-
Functional Imaging in Lung SBRT
NCT03121300 ·Status: COMPLETED
-
Radiation Treatment Plan Evaluation Learning Tool Pilot Project
NCT06115811 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRT
NCT04081428 ·Status: ACTIVE_NOT_RECRUITING
-
MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer
NCT02582931 ·Status: COMPLETED ·Phase: PHASE1
-
Stereotactic Body Radio Therapy (SBRT) for Early-stage Non Small Cell Lung Cancer (NSCLC)
NCT00870116 ·Status: UNKNOWN ·Phase: NA
-
Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer
NCT02296229 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prospective Evaluation of Stereotactic Body Radiotherapy for Metastatic Prostate Cancer
NCT02206724 ·Status: WITHDRAWN ·Phase: NA
-
Stereotactic Body Radiotherapy (SBRT) Post Prostatectomy
NCT04848909 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer
NCT00955695 ·Status: UNKNOWN ·Phase: PHASE3
-
Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma
NCT04974671 ·Status: RECRUITING ·Phase: PHASE2
-
Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
NCT00057746 ·Status: COMPLETED ·Phase: PHASE2
-
Prophylactic Cranial Irradiation in Patients With Lung Adenocarcinoma With High Risk of Brain Metastasis
NCT01603849 ·Status: COMPLETED ·Phase: NA
-
SBRT for Organ Confined Prostate Cancer
NCT02653248 ·Status: COMPLETED ·Phase: PHASE1